Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
Crossref DOI link: https://doi.org/10.1007/s12325-020-01394-y
Published Online: 2020-06-12
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abraham, Pranav
Gricar, Joe
Zhang, Ying
Shankaran, Veena
Funding for this research was provided by:
Bristol-Myers Squibb
Text and Data Mining valid from 2020-06-12
Version of Record valid from 2020-06-12
Article History
Received: 8 April 2020
First Online: 12 June 2020